RNA-binding protein Raly (RALY) Peptid
RALY
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle Raly (RALY) Produkte
- Raly (RALY) (RNA-binding protein Raly (RALY))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- GGGSSRPPAP QENTTSEAGL PQGEARTRDD GDEEGLLTHS EEELEHSQDT
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of RALY antibody,
Alternative Names: RALY control peptide, RALY antibody Blocking Peptide, Anti-RALY Blocking Peptide, RNA Binding Protein Autoantigenic Blocking Peptide, Hnrnp-Associated With Lethal Yellow Homolog Blocking Peptide, MGC117312 Blocking Peptide, P542 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- Raly (RALY) (RNA-binding protein Raly (RALY))
- Hintergrund
- In infectious mononucleosis, anti-EBNA-1 antibodies are produced which cross-react with multiple normal human proteins. The cross-reactivity is due to anti-gly/ala antibodies that cross-react with host proteins containing configurations like those in the EBNA-1 repeat. One such antigen is RALY which is a member of the heterogeneous nuclear ribonucleoprotein gene family.In infectious mononucleosis, anti-EBNA-1 antibodies are produced which cross-react with multiple normal human proteins. The cross-reactivity is due to anti-gly/ala antibodies that cross-react with host proteins containing configurations like those in the EBNA-1 repeat. One such antigen is RALY which is a member of the heterogeneous nuclear ribonucleoprotein gene family.
- Molekulargewicht
- 32 kDa
-
Sie sind hier:
